Both Semaglutide and the drug represent groundbreaking approaches to treating type 2 diabetes, and increasingly, obesity. Tirzepatide is a twin receptor activator that impacts multiple chemicals involved in metabolism: the incretin hormone and another incretin. This medication, often viewed as a